In November 2013, US-based Merck’s patent on hair damage treatment Propecia (made up of Finasteride 1mg) finally expired. Thereafter, numerous generic versions of post propecia syndrome <a href=" finasteride</a> keep come into the US shop at a small fraction of the expense of Propecia.
